Bildkälla: Stockfoto

ChromoGenics Q2 2023: Weak on topline but better margins due better cost control and yield in production - Redeye

Weak on topline but better margins due better cost control and yield in production.

Weak on topline but better margins due better cost control and yield in production.
Börsvärldens nyhetsbrev
ANNONSER